Hypoparathyroidism: New Insights into Epidemiology, Etiology, Presentation and Therapeutic Options
A CME-certified Symposium held in conjunction with the 84th Annual Meeting of the American Thyroid Association

Registration Statement

By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


View Agenda  Hotel del CoronadoCoronado,CA Saturday
Nov 1, 2014 6:30 PM


Download (PDF) Program Slides Click here to view the presentation slides from this CME-certified symposium. Download (PDF)

Program Description

Hypoparathyroidism is a rare endocrine disorder, affecting 37 out of 100,000 people in the US, with physical and cognitive manifestations that profoundly affect a patient's quality of life. Importantly, there are no formal guidelines for the management of these complicated patients. Current management of hypoparathyroidism is based on clinical judgment and experience, attempts to address mineral abnormalities, and involves the use of high doses of oral calcium and calcitriol (active vitamin D) to facilitate intestinal calcium absorption.

Hypoparathyroidism: New Insights into Epidemiology, Etiology, Presentation, and Therapeutic Options will provide clinicians who care for patients with thyroid diseases the latest information on the management of hypoparathyroidism through expert guidance and evidence-based recommendations. The activity will allow clinicians to better recognize the condition and safely and effectively manage such complex patients.


John P. Bilezikian, MD
Dorothy L. and Daniel H. Silberberg Professor of Medicine
Professor of Pharmacology
Chief, Division of Endocrinology
College of Physicians and Surgeons, Columbia University
Department of Medicine
New York, NY

Michael Mannstadt, MD
Assistant Professor in Medicine
Harvard and Massachusetts General Hospital
Boston, MA

Dolores Shoback, MD
Professor of Medicine
University of California
San Francisco, CA

Target Audience

This activity is intended for endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, and other health care professionals with a shared special interest in the thyroid gland and its disorders.

Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Apply an increased understanding of the prevalence, causes, and risk factors for hypoparathyroidism to proactive screening of those at risk
  • Identify the potential clinical manifestations of hypoparathyroidism, including in patients with early and long-standing hypoparathyroidism
  • Recognize the limitations of current management strategies and evaluate the rationales, findings, and implications of recent studies on PTH replacement therapy in the management of hypoparathyroidism


  • Welcome and Introduction
  • Epidemiology, Etiologies, and Diagnosis of Hypoparathyroidism – An Update
  • Clinical Manifestations of Hypoparathyroidism
  • Current and Future Treatments for Hypoparathyroidism
  • Q&A Session and Concluding Remarks


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category I credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, the post-test, or evaluation, please email contact@rockpointe-pcme.com.

Disclosure Information

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

Method of Participation

To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME-certificate will be emailed to participants upon submission of a completed evaluation form.

There are no fees associated with this program.


Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.).

Please email specialservices@rockpointe-pcme.com at least 5 days prior to the program.



Supported By

Supported by an educational grant from NPS Pharmaceuticals, Inc.

Registration Statement

By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.

Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.


View Agenda  Hotel del CoronadoCoronado,CA Saturday
Nov 1, 2014 6:30 PM